These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15909458)

  • 21. Selective adhesion-molecule therapy and inflammatory bowel disease--a tale of Janus?
    Podolsky DK
    N Engl J Med; 2005 Nov; 353(18):1965-8. PubMed ID: 16267329
    [No Abstract]   [Full Text] [Related]  

  • 22. Early changes on electroencephalography in natalizumab-associated progressive multifocal leucoencephalopathy.
    Kleiter I; Schröder M; Lürding R; Schuierer G; Clifford DB; Bogdahn U; Steinbrecher A; Pöschl P
    Mult Scler; 2010 Jun; 16(6):749-53. PubMed ID: 20453014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective adhesion-molecule therapy and inflammatory bowel disease.
    Chaudhuri A
    N Engl J Med; 2006 Feb; 354(6):644-5; author reply 644-5. PubMed ID: 16467556
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti-JC-virus antibody prevalence in a German MS cohort.
    Warnke C; Dehmel T; Posevitz-Fejfár A; Chan A; Berthele A; Schmidt S; Haas J; Kronsbein HC; Seitz F; Tackenberg B; Mäurer M; Gerbershagen K; Limmroth V; Adams O; Hartung HP; Gold R; Hemmer B; Wiendl H; Kieseier BC
    Mult Scler; 2012 Jul; 18(7):1054-5. PubMed ID: 22740609
    [No Abstract]   [Full Text] [Related]  

  • 25. Lessons for clinical trials from natalizumab in multiple sclerosis.
    Chaudhuri A
    BMJ; 2006 Feb; 332(7538):416-9. PubMed ID: 16484271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis.
    Alvarez-Cermeño JC; Masjuan J; Villar LM
    N Engl J Med; 2005 Oct; 353(16):1744-6; author reply 1744-6. PubMed ID: 16240475
    [No Abstract]   [Full Text] [Related]  

  • 27. Fatalities in natalizumab treatment--a 'no go' for leukocyte recirculation approaches?
    Li YY; Perez HD; Zollner TM
    Expert Opin Ther Targets; 2006 Aug; 10(4):489-99. PubMed ID: 16848686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progressive multifocal leukoencephalopathy after fludarabine therapy for low-grade lymphoproliferative disease.
    Vidarsson B; Mosher DF; Salamat MS; Isaksson HJ; Onundarson PT
    Am J Hematol; 2002 May; 70(1):51-4. PubMed ID: 11994982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Natalizumab in multiple sclerosis: unclear patient benefits].
    Schipper JP
    Ned Tijdschr Geneeskd; 2007 Apr; 151(15):852-5. PubMed ID: 17472115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective treatment of multiple sclerosis.
    Ropper AH
    N Engl J Med; 2006 Mar; 354(9):965-7. PubMed ID: 16510751
    [No Abstract]   [Full Text] [Related]  

  • 31. Treating multiple sclerosis with natalizumab.
    Iaffaldano P; Lucchese G; Trojano M
    Expert Rev Neurother; 2011 Dec; 11(12):1683-92. PubMed ID: 22091593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Balancing risk and reward: the question of natalizumab.
    Hauser SL; Johnston SC
    Ann Neurol; 2009 Sep; 66(3):A7-8. PubMed ID: 19810091
    [No Abstract]   [Full Text] [Related]  

  • 33. Progressive multifocal leukoencephalopathy, efalizumab, and immunosuppression: a cautionary tale for dermatologists.
    Korman BD; Tyler KL; Korman NJ
    Arch Dermatol; 2009 Aug; 145(8):937-42. PubMed ID: 19687432
    [No Abstract]   [Full Text] [Related]  

  • 34. [Monoclonal antibodies in multiple sclerosis].
    Papeix C; Lubetzki C
    Med Sci (Paris); 2009 Dec; 25(12):1113-5. PubMed ID: 20035688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natalizumab treatment for multiple sclerosis.
    Ferreira ML
    Arq Neuropsiquiatr; 2014 Dec; 72(12):911-2. PubMed ID: 25517640
    [No Abstract]   [Full Text] [Related]  

  • 36. Natalizumab and immune cells.
    McFarland HF; Jacobson S
    Arch Neurol; 2006 Oct; 63(10):1366-7. PubMed ID: 17030649
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of multiple sclerosis].
    Holmøy T; Harbo HF; Celius EG
    Tidsskr Nor Laegeforen; 2010 May; 130(9):923; author reply 923. PubMed ID: 20453948
    [No Abstract]   [Full Text] [Related]  

  • 38. The trials and tribulations of Tysabri.
    Lancet Neurol; 2006 May; 5(5):373. PubMed ID: 16632299
    [No Abstract]   [Full Text] [Related]  

  • 39. Mycophenolate: encephalopathy.
    Prescrire Int; 2008 Dec; 17(98):245. PubMed ID: 19431230
    [No Abstract]   [Full Text] [Related]  

  • 40. Fingolimod-induced remission in a patient with ulcerative colitis and multiple sclerosis.
    Ladrón Abia P; Alcalá Vicente C; Martínez Delgado S; Bastida Paz G
    Gastroenterol Hepatol; 2021 Feb; 44(2):156-157. PubMed ID: 33199131
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.